Intensiv care medicine 2007;Intensivmedizin 2007

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 25-26, 2007, Pages 1383-1387

  Werdan, Karl ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; CORTICOSTEROID; SELENIUM;

ADULT RESPIRATORY DISTRESS SYNDROME; AUTONOMIC NERVOUS SYSTEM; CARDIOGENIC SHOCK; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; ESCHERICHIA COLI; HUMAN; INFLAMMATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; PROGNOSIS; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGE; CONGESTIVE HEART FAILURE; CRITICAL ILLNESS; INTENSIVE CARE; METHODOLOGY; MULTIPLE ORGAN FAILURE; REVIEW;

ADRENAL CORTEX HORMONES; AGE FACTORS; CRITICAL ILLNESS; HEART FAILURE, CONGESTIVE; HUMANS; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTENSIVE CARE; MULTIPLE ORGAN FAILURE; QUALITY OF LIFE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SELENIUM; SEPSIS; SHOCK, CARDIOGENIC;

EID: 34347217094     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-982039     Document Type: Note

References (25)

1. Almog Y, Novack V, Eisinger M et al. The effect of statin therapy on infection-related mortality in patients with atheroslerotic diseases. Crit Care Med 2007; 35: 372-378. Editorial: 631-632
2. Andrews P, Azoulay E, Antonelli M et al. Year in review in Intensive Care Medicine 2006. Intensive Care Med 2007; 33: 49-57, 214-229, 414-422
3. Angstwurm MWA, Engelmann L, Zimmermann T et al. Selenium in Intensive Care (SIC): Results of a prospective, randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35: 118-126
4. Annane D, Sébille V, Bellissant E for the Ger-Inf-05 Study Group. Effect of low doses of corticosteroids in septic shock patients with or without early respiratory distress syndrome. Crit Care Med 2007; 34: 22-30
5. Brunkhorst FM, Werdan K. Intensivmedizin - nach den positiven Studien kommen die Fragen. Dtsch Med Wochenschr 2006; 131: 1441-1444
6. Brunner-Ziegler S, Heinze G, Ryffel M, Kompatscher M, Slany J, Valentin A. "Oldest old" patients in intensive care: prognosis and therapeutic activity. Wien Klin Wochenschr 2007; 119/1-2: 14-19
7. Chua D, Tsang RS, Kuo IF. The role of statin therapy in sepsis. Ann Pharmacother 2007; 41: 647-652
8. Dowdy DW, Eid MP, Dennison CR et al. Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med 2006; 32: 1115-1124
9. Gupta R, Plantinga LC, Fink NE et al. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007; 297/13: 1455-1464
10. Kaarlola A, Tallgren M, Pettilä V. Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients. Crit Care Med 2006; 34: 2120-2126
11. Lipiner-Friedman D, Sprung CL, Laterre PF et al.; for the Corticus Study Group. Adrenal function in sepsis: The retrospective Corticus cohort study. Crit Care Med 2007; 35: 1012-1018
12. Majumdar SR, McAllister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333: 999-1001; Kommentare: 333: 980-981; 333: 1123-1124
13. Marik PE. Management of the critically ill geriatric patient. Crit Care Med 2006(Suppl34: S176-S182
14. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34: 15-21
15. Martin CP, Talbert RL, Burgess DS, Peters JI. Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. Pharmacotherapy 2007; 27: 20-26
16. Müller-Werdan U. Besonderheiten bei älteren Intensivpatientinnen und Intensivpatienten. Arzneimittel Forschung Drug Research 2006; 56/11: 31-32
17. Prondzinsky R, Lemm H, Swyter M et al. A Prospective, Randomized Evaluation of Intraaortic Balloon Counterpulsation for the Prevention of Multiorgan-Dysfunction and -Failure in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation 2006; 114/18 (Suppl I): 11-555
18. Schmidt H, Hennen R, Keller A et al. Association of statin therapy and increased survival in patients with multiple organdys-function syndrome. Intensive Care Med 2006; 32: 1248-1251
19. Schmidt H, Hennen R, Werdan K, Buerke M. Statine: Der nächste Schritt in der adjuvanten Sepsistherapie? INTENSIV-NEWS 2007; 10: 1-4
20. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007; 7: 358-368
21. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of Two Fluid-Management Strategies in Acute Lung Injury. N England J Med 2006; 354: 2564-2575; Editorial: 2598-2600
22. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome. N EnglJ Med 2006; 354: 1671-1684
23. The TRIUMPH Investigators. Effect of Tilarginine Acetate in Patients with Myocardial Infarction and Cardiogenic Shock - The TRIUMPH Randomized and Controlled Trial. JAMA 2007; 297: 1657-1666
24. Torres OH, Francia E, Longobardi V, Gich I, Benito S, Ruiz D. Short- and longterm outcomes of older patients in intermediate care units. Intensive Care Med 2006; 32: 1052-1059
25. Vincent J-L, Sakr Y, Sprung CL et al.; on behalf of the Sepsis Occurrence in Acutely III Patients Investigators. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353